Rank #14 in Food & Personal Care Products
These four figures are AlphaGen model outputs, not company-reported figures. The TTM Performance Score was unavailable and has not been estimated.
Big Bird Foods ended FY2026 with another year of strong revenue growth and materially higher operating profit, but the closing quarter exposed a clear earnings-quality split. Full-year sales rose about 30% to Rs14.76 billion and profit before tax increased about 37%, helped by lower finance cost and higher other income. Yet profit after tax increased only about 4% because the tax charge more than doubled. The implied June quarter was softer still: revenue and gross profit edged higher, but operating profit, pre-tax profit and net profit all declined as other income fell, finance cost rose and taxation increased. The main question for the next cycle is therefore whether BBFL can sustain top-line growth while improving post-tax conversion and funding working-capital expansion without allowing inventory, biological assets and receivables to absorb too much capital.
The strongest full-year improvement was scale. Revenue rose nearly 30% while gross margin remained almost unchanged. That allowed gross profit to increase by roughly Rs690 million and operating profit to rise by about Rs556 million. The nine-month report shows the same pattern before year-end: management reported 41% sales growth through March and attributed the improvement to stronger market penetration, improved consumer demand and execution of commercial initiatives. Those are management explanations for the nine-month period, not independent proof of the precise contribution of each driver.
Funding cost also improved at the full-year level. Finance cost fell to Rs316.7 million from Rs343.5 million even though the business carried a large financing requirement through the year. The March interim report had already linked lower finance cost to repayment of borrowings and prudent financial management. By June, short-term borrowings were nil, although the current portion of long-term financing had risen materially. The annual result therefore shows a shift in the liability mix rather than a simple disappearance of debt.
The balance sheet also became stronger in headline solvency terms. Equity increased to Rs10.54 billion from Rs7.57 billion, reflecting retained earnings, share capital, share premium and revaluation surplus. Current assets grew much faster than current liabilities, lifting the current ratio to roughly 1.86x from about 1.52x. The company therefore ended FY2026 with a larger liquidity cushion on accounting measures, even though cash itself declined.
Management had also completed a major capital-structure step before year-end. The March statement of changes in equity shows the conversion of Rs1.5 billion of a directors’ loan into equity, including additional share capital and share premium. This reduced related-party loan exposure and increased permanent equity funding. Because the full annual report has not yet been published, this article does not infer any transaction details beyond those explicitly shown in the interim statements and year-end balance sheet.
The most important weakness is the gap between pre-tax and post-tax earnings growth. Profit before tax rose 37.3%, but PAT rose only 4.4%. The annual tax charge increased to Rs975.6 million from restated Rs442.2 million. The compact year-end filing does not provide the tax-note reconciliation, so it would be unsafe to assign the increase to current tax, deferred tax, minimum tax, prior-year adjustments or any other specific item. The full annual report is needed before deciding how much of the FY2026 tax burden is recurring.
Working capital expanded rapidly. Stock in trade rose 52.9% to Rs2.926 billion, biological assets increased to Rs735.9 million from Rs254.8 million, and trade debts rose 17.4% to Rs2.298 billion. These increases are economically consistent with a larger poultry processing business, but they also mean more capital is tied up in inventory, birds and customer receivables. Trade and other payables rose 43.2% to Rs1.436 billion, showing that suppliers also financed part of the expansion.
Cash and bank balances fell 17.3% to Rs270.2 million despite the larger balance sheet and higher earnings. The official year-end result does not include a cash-flow statement, and the full annual report has not yet been transmitted. For that reason, this article does not invent FY2026 operating cash flow, free cash flow or capex cash-flow figures. Until the annual report is available, the safest liquidity assessment comes from the published balance-sheet movement: cash fell while inventory, biological assets, receivables and property, plant and equipment all increased.
Property, plant and equipment rose to Rs10.216 billion from Rs7.701 billion, an increase of roughly one-third. This shows that BBFL continued to expand its operating asset base. Without the annual cash-flow statement and fixed-asset note, however, the split between additions, revaluation, depreciation and other movements cannot be quantified confidently. The next detailed report should therefore be checked for capex, commissioning status, capacity utilization and whether the higher asset base is producing enough incremental operating cash.
The implied Q4 bridge is important because it shows that the year did not finish with the same earnings momentum seen through March. Subtracting the official nine-month numbers from the official full-year result gives Q4 sales of about Rs3.182 billion versus Rs3.128 billion a year earlier, an increase of 1.7%. Gross profit rose 2.5% to about Rs655.9 million and gross margin edged up to roughly 20.6% from 20.4%. The gross-profit engine therefore did not collapse.
Below gross profit, however, the picture softened. Implied Q4 operating profit was about Rs588.9 million, down 1.5% year on year. Other income fell about 34% to Rs162.1 million, finance cost increased about 11% to Rs72.2 million, and profit before tax declined about 3% to Rs516.6 million. Taxation increased roughly 12% to Rs350.5 million, leaving Q4 PAT of about Rs166.1 million, down 24.4%. Net margin fell to about 5.2% from 7.0%.
This distinction matters for earnings quality. The Q4 deterioration was not primarily a gross-margin collapse; it came from weaker conversion below gross profit, including lower other income, higher finance cost and a heavier tax charge. The full annual notes may reveal additional year-end accounting details, so the Q4 bridge should be treated as a derived analytical view rather than a separately reported quarterly statement.
The recurring positives are revenue growth, broadly stable gross margin and sustained operating profitability. BBFL’s core processing business generated substantially more sales and gross profit in FY2026 than in FY2025, and the nine-month report linked that growth to demand, distribution, procurement and production planning. Those are the operating variables that matter most for the next cycle.
The less predictable elements are other income and taxation. Other income rose 47.2% for the full year to Rs448.4 million but fell sharply in the implied Q4. Because the year-end result does not disclose its detailed composition, it should not automatically be capitalized as recurring operating income. The same caution applies to taxation: the large annual increase is factual, but its recurring portion cannot be established until the annual tax notes are available.
Finance cost appears more structural than exceptional because the business remains capital intensive and working-capital heavy. Although the annual charge declined, Q4 finance cost increased year on year and the company still carried roughly Rs1.91 billion of long-term/current-portion financing at June 30. The shift away from short-term borrowing is constructive, but future earnings remain sensitive to debt levels, facility pricing and the amount of capital tied up in inventory and receivables.
On July 16, 2026, after the FY2026 reporting date, BBFL disclosed that it had secured a significant export order from a Gulf-based halal food company for raw chicken and further processed poultry products. Management said the order was expected to approximately double current export volumes and, based on its projections, add about Rs1.2 billion in annual revenue. This is a material post-period development for the next result cycle, but it is a management projection, not FY2026 revenue and not a guaranteed earnings contribution.
The economic importance of the export order depends on more than headline revenue. The key questions are production capacity, product mix, realized pricing, freight and cold-chain costs, working-capital requirements, payment terms and the margin profile of export sales versus domestic channels. The disclosure also says further upside could come as production capacity expands and additional product categories are introduced. Those statements should be treated as forward-looking management expectations until confirmed in reported volumes and margins.
Pakistan’s poultry market remains large and price-sensitive. The Pakistan Economic Survey 2025-26, using official price data, showed farm chicken prices in April 2026 were about 5.5% lower than a year earlier. That does not directly determine BBFL’s realized processed-food pricing, but it illustrates the volatility of the underlying poultry value chain. For a vertically connected poultry processor, live-bird economics, feed/input costs, consumer demand, cold-chain execution and product mix can all influence gross margin even when reported sales are growing.
BBFL’s own business model spans poultry farming, slaughtering, processing and supply of finished and semi-finished poultry products. That integration gives the company more control over production and processing, but it also explains why biological assets, inventories and fixed assets are significant balance-sheet items. A close listed processed-poultry peer with sufficiently comparable disclosures is not available, so this analysis does not force a misleading peer-margin comparison.
The recent financial pattern is one of rapid scale expansion with thinner post-tax conversion. FY2025 itself represented a major step up from FY2024, and FY2026 extended that growth: sales rose to Rs14.76 billion from Rs11.36 billion and operating profit rose to Rs2.46 billion. Yet net margin declined to 7.9% from 9.9% because the tax burden absorbed much of the operating improvement. The business is therefore no longer being tested mainly on whether it can grow; the more important test is whether growth can convert into stable post-tax profit and cash without an outsized working-capital build.
The implied Q4 reinforces that point. Gross margin held up, but net margin weakened sharply. That makes the next result cycle especially useful: if export growth, domestic demand and capacity expansion are accompanied by lower tax normalization, controlled finance cost and better working-capital conversion, the FY2026 operating expansion will look higher quality. If inventories and receivables continue to rise faster than cash generation, the balance-sheet cost of growth will become more important.
Overall, Big Bird Foods’ FY2026 result shows a growing and operationally profitable poultry platform, but not a uniformly stronger earnings profile. Sales and operating profit grew strongly, finance cost improved for the year, and equity strengthened. At the same time, post-tax conversion weakened, Q4 PAT fell, cash balances declined and working-capital assets expanded materially. The post-period export contract creates a meaningful new growth avenue, but the next result needs to demonstrate that this additional scale translates into durable margins, cash generation and balance-sheet efficiency. This analysis is informational and does not constitute buy or sell advice.